Close Menu

NEW YORK (GenomeWeb) – Guardant Health announced today that it expects to raise gross proceeds of $237.5 million from its initial public offering, more than double the firm's original goal of $100 million when it filed plans to list its shares on the Nasdaq in September.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.